Our experimental results showed that administration of an anti-IL-10 antibody triggers the anti-tumoral action of mifamurtide in all OS cells tested, leading to a dramatically decreased survival of tumor cells in macrophage-tumor co-culture in vitro and a drastic reduction of OS cell retention in the lungs of mice in vivo. Here, IL10 is linked to neoplasm.